2016
DOI: 10.1093/qjmed/hcw051
|View full text |Cite
|
Sign up to set email alerts
|

PulmonaryMycobacterium szulgaiinfection: a case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(13 citation statements)
references
References 5 publications
0
13
0
Order By: Relevance
“…Mycobacterium szulgai is a slow-growing, opportunistic, non-tuberculous mycobacterium (NTM). M. szulgai was so named after Dr T. Szulga who developed the lipid analysis technique used to detect this rare but serologically distinct organism (Khan et al., 2016). First identified in 1972, it is known to infect the lungs.…”
mentioning
confidence: 99%
“…Mycobacterium szulgai is a slow-growing, opportunistic, non-tuberculous mycobacterium (NTM). M. szulgai was so named after Dr T. Szulga who developed the lipid analysis technique used to detect this rare but serologically distinct organism (Khan et al., 2016). First identified in 1972, it is known to infect the lungs.…”
mentioning
confidence: 99%
“…to be diagnosed accurately. 4 Moreover, there is no consensus recommendation for treatment of M szulgai infections, probably due to its low prevalence. 5 Herein, we present a case of M szulgai pulmonary infection in an immunocompetent patient without any history of tuberculosis or consumption of immunosuppressive drugs but severely deficient in vitamin D that was successfully treated in Mashhad, Iran.…”
Section: Introductionmentioning
confidence: 99%
“…Mycobacterium szulgai pulmonary infections are infrequently reported in those with a history of chronic obstructive pulmonary disease (COPD), tuberculosis, or immunosuppression 3 . Clinically, it is indistinguishable from Mycobacterium tuberculosis infection and neoplasm; therefore, it is critical to be diagnosed accurately 4 . Moreover, there is no consensus recommendation for treatment of M szulgai infections, probably due to its low prevalence 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Mycobacterium szulgai , a slow-growing NTM, is a relatively rare pathogen, accounting for less than 0.2% of isolated strains in a study of over 36,000 NTM samples from 14 countries throughout Europe and the Middle East. 1–3 Pulmonary infection is the most common manifestation of M. szulgai infection; however, it may be clinically and radiologically confused with active pulmonary tuberculosis. Extra-pulmonary infections due to this organism have been reported in the form of tenosynovitis of the hand, olecranon bursitis, osteomyelitis, keratitis, cervical lymphadenitis, and renal or cutaneous infection.…”
Section: Introductionmentioning
confidence: 99%
“…4 M. szulgai was named after Dr T Szulga, a Polish microbiologist, who developed the lipid analysis method to identify this pathogen. 5,6 It has been recovered from primarily environmental sources, including snails, aquarium water, swimming pools, tropical fish and hospital water supplies, 1,2,4,7 and at present, no human-to-human transmission has been reported. 2,8 However, some case reports illustrate that M. szulgai can cause disease by hematogenous spread.…”
Section: Introductionmentioning
confidence: 99%